Ticagrelor to Reduce Myocardial Injury in Patients With High-Risk Coronary Artery Plaque.

导出 OA

翻译打印收藏纠错

第一作者： Alastair J,Moss

第一单位： British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: alastairmoss@gmail.com.

作者： Alastair J,Moss ^[1] ; Marc R,Dweck ^[2] ; Mhairi K,Doris ^[2] ; Jack P M,Andrews ^[2] ; Rong,Bing ^[2] ; Rachael O,Forsythe ^[2] ; Timothy R,Cartlidge ^[2] ; Tania A,Pawade ^[2] ; Marwa,Daghem ^[2] ; Jennifer B,Raftis ^[3] ; Michelle C,Williams ^[4] ; Edwin J R,van Beek ^[4] ; Laura,Forsyth ^[5] ; Steff C,Lewis ^[5] ; Robert J,Lee ^[5] ; Anoop S V,Shah ^[6] ; Nicholas L,Mills ^[6] ; David E,Newby ^[4] ; Philip D,Adamson ^[7]

作者单位： British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: alastairmoss@gmail.com. ^[1] British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. ^[2] Medical Research Council Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom. ^[3] British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Edinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom. ^[4] Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, United Kingdom. ^[5] British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom. ^[6] British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Christchurch Heart Institute, University of Otago, Christchurch, New Zealand. ^[7]

关键词 (18)F-fluoride myocardial infarction troponin